CellCarta

CellCarta offers its pharmaceutical partners worldwide a wide range of services to support the development of therapeutic modalities, biomarkers and companion diagnostic tests, covering both preclinical and clinical stages.
For example, in support of the clinical development of RNA vaccines, CellCarta leverages its multiple state-of-the-art technology platforms, including flow cytometry and ELISpot for immune response monitoring, and its genomics and histopathology platforms for quantifying cellular responses in tissues. In addition, by combining its platforms, CellCarta offers cutting-edge services in spatial transcriptomics and single-cell analysis, providing comprehensive support for your bioanalysis projects.